Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.
- Published in:
- Current Medical Literature: Pulmonary Hypertension, 2011, v. 2, n. 2, p. 75
- By:
- Publication type:
- Article
Works matching IS 20411693 AND DT 2011 AND VI 2 AND IP 2
Results: 22
1
2
Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy.
- Published in:
- Current Medical Literature: Pulmonary Hypertension, 2011, v. 2, n. 2, p. 75
- By:
- Publication type:
- Article
3
Systemic evaluation of platelet and leukocyte activation and interaction in a rat model of pulmonary arterial hypertension.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
4
Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
5
Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMa) increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
6
Transforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
7
Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
8
Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
9
Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
10
Involvement of reactive oxygen species in thrombin-induced pulmonary vasoconstriction.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
11
PPARy regulates hypoxia-induced NOX4 expression in human pulmonary artery smooth muscle cells through NF-κB.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
12
Endothelial function and hemodynamics in systemic sclerosis.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
13
Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
14
Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
15
Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis- associated pulmonary arterial hypertension.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
16
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
17
Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
18
Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
19
Right ventricular inefficiency in repaired tetralogy of Fallot: proof of concept for energy calculations from cardiac MRI data.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
20
Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
21
Sickle Cell Disease-Associated Pulmonary Hypertension: the Effect of Anemia and High Cardiac Output.
- Published in:
- Current Medical Literature: Pulmonary Hypertension, 2011, v. 2, n. 2, p. 45
- By:
- Publication type:
- Article
22
Foreword.
- Published in:
- Current Medical Literature: Pulmonary Hypertension, 2011, v. 2, n. 2, p. 45
- Publication type:
- Article